Generic Name: Lorazepam
Ativan is a brand name for lorazepam, a benzodiazepine, used in the treatment of anxiety disorders. It is used intravenously for status epilepticus. Off label it is used for alcohol detoxification; insomnia; partial complex seizures; agitation; and as an adjunct in antiemetic treatment.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Anxiety | 141 |
|
|
|
|
39 | |
| Insomnia | 42 |
|
|
|
|
16 | |
| Other | 22 |
|
|
|
5 | ||
| Panic attacks | 15 |
|
|
|
5 | ||
| Treat my mood condition(s) | 13 |
|
|
|
5 | ||
| Social anxiety/phobia | 7 |
|
|
2 |
See all 215 patients currently taking Ativan
Mouse over the table for more information
Top 10 dosages based on patients currently taking Ativan. See all 33 dosages ►
| 0.25mg as needed | 0.5 0.5mg as needed | 0.5 mg as needed | 0.5mg as needed | 0mg as needed | 1 mg as needed | 1mg as needed | 2 0.5mg as needed | 2 1mg as needed | 2 2mg as needed | 2 2mg/mL as needed | 2mg as needed | 2mg/mL as needed | 4 mg as needed | 500mg as needed | 5mg as needed | as needed | daily | 1 mg weekly | 0.5 mg daily | 0.75 mg daily | 1 mg daily | 1.5 mg daily | 2 mg daily | 2.5 mg daily | 3 mg daily | 4 mg daily | 6 mg daily | 8 mg daily | 10 mg daily | 12 mg daily | 30 mg daily | 100 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
3
|
39
|
1
|
1
|
35
|
4
|
3
|
1
|
1
|
4
|
2
|
1
|
1
|
2
|
1
|
1
|
1
|
12
|
1
|
38
|
7
|
28
|
1
|
11
|
11
|
2
|
2
|
1
|
1
|
1
|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Other
|
19 | 39% |
|
|
Doctor's advice
|
13 | 27% |
|
|
Side effects too severe
|
9 | 18% |
|
|
Did not seem to work
|
6 | 12% |
|
|
Course of treatment ended
|
4 | 8% |
|
|
Expense
|
3 | 6% |
|
|
Personal research
|
1 | 2% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 23, 2009.